Hunan Jiudian Pharmaceutical Co.Ltd(300705) independent director
Prior approval opinions on joint investment and related party transactions with professional investment institutions
In accordance with the Shenzhen Stock Exchange GEM Listing Rules, Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 2 – standardized operation of GEM listed companies, guidance on the establishment of independent director system in listed companies, working rules for independent directors and other relevant laws, regulations and rules, As an independent director of Hunan Jiudian Pharmaceutical Co.Ltd(300705) (hereinafter referred to as “the company”), based on the position of objective and independent judgment, we express our prior approval opinions on joint investment and related party transactions with professional investment institutions as follows:
The company’s joint investment with professional institutions meets the needs of the company’s development strategy, is conducive to the long-term development of the company and is in line with the interests of the company and all shareholders. This transaction follows the principles of fairness, voluntariness and fairness, and there is no damage to the interests of the company and all shareholders, especially minority shareholders. Therefore, we agree to submit the joint investment and related party transactions between the company and professional institutions to the board of directors for consideration. When the board of Directors considers the matter, the related directors shall avoid voting.
(there is no text below, and the next page is the signature page)
(there is no text on this page, which is the signature page of Hunan Jiudian Pharmaceutical Co.Ltd(300705) independent director’s prior approval opinions on joint investment and connected transactions with professional investment institutions) signature of independent director:
From Yangzhou to Linjing
